Interplay between genetic determinants of glycaemia type 2 diabetes and cardiov...
Interplay between genetic determinants of glycaemia type 2 diabetes and cardiovascular disease in interaction with dietary and lifestyle factors
Genome-wide association studies (GWAS) for complex traits, including glycaemia, type 2 diabetes (T2D) and coronary heart disease (CHD) have been successful in identifying genetic variants associated with those phenotypes. However,...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NASCENT
Novel Approach to Systematically Characterize Exercise and...
2M€
Cerrado
PAINTBOX
Pancreatic islet dysfunction and type 2 diabetes beyond th...
2M€
Cerrado
BIOMENDELIAN
Linking Cardiometabolic Disease and Cancer in the Level of G...
2M€
Cerrado
GENETICS OF T1D
Using gene to phenotype studies to identify type 1 diabetes...
50K€
Cerrado
GENE TARGET T2D
General and targeted approaches to unravel the molecular cau...
2M€
Cerrado
METSGENES
Genes Mediterranean dietary pattern and metabolic syndrome...
224K€
Cerrado
Información proyecto INTERPLAY
Duración del proyecto: 59 meses
Fecha Inicio: 2016-02-19
Fecha Fin: 2021-02-06
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Genome-wide association studies (GWAS) for complex traits, including glycaemia, type 2 diabetes (T2D) and coronary heart disease (CHD) have been successful in identifying genetic variants associated with those phenotypes. However, they explained only a small proportion of the estimated heritability. Possible reasons include the interplay between genetics and lifestyle determinants, small-effect variants, structural variations and the difficult to characterize non-coding functional variants that interact with other genetic regions. This proposal, in a new era of precision medicine, englobes the systematic study of the interplay between genetic variants associated with glycaemia, T2D, CHD and dietary and lifestyle factors. We propose to conduct a comprehensive analysis of gene and gene-lifestyle interaction, including the existing international GWAS consortia of CARDIoGRAM, DIAGRAM, MAGIC, the U.S. based DPP clinical trial, and the European-wide networks of EPIC-InterAct and PREDIMED. We will test hypothesis about: 1) whether genetically driven hyperglycaemia increases risk of CHD, 2) the association between genetic determinants of CHD and intermediate metabolic phenotypes, and 3) whether dietary components and lifestyle changes influence these associations. Finally, we will extend and replicate these previous results in two independent populations, and to deploy a new method to identify implicated biological pathways. Information that will emerge from that project will provide valuable insights into missing heritability for T2D and CHD. Specifically we expect to uncover genetic determinants for faster CHD progression in T2D, identifying vulnerable individuals who are more likely to experience a differential response to current prevention strategies and to validate potential targets and avenues for intervention. The experienced researcher will emerged from the project with new skills, and the capability to launch his own research group in Europe.